首页> Journal of cancer research and clinical oncology> Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.

Prevalence and clinical significance of RBM3 immunostaining in non-small cell lung cancers.

导出 OA

翻译打印收藏纠错

第一作者： Nathaniel,Melling

第一单位： General-, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

作者： Nathaniel,Melling ^[1] ; Kai,Bachmann ^[1] ; Bianca,Hofmann ^[1] ; Alexander Tarek,El Gammal ^[1] ; Matthias,Reeh ^[1] ; Oliver,Mann ^[1] ; Christoph,Moebius ^[2] ; Marco,Blessmann ^[2] ; Jakob Robert,Izbicki ^[1] ; Katharina,Grupp ^[3]

作者单位： General-, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[1] Department of Plastic-, Reconstructive and Aesthetic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. ^[2] General-, Visceral and Thoracic Surgery Department and Clinic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. k.grupp@uke.de.;Department of Plastic-, Reconstructive and Aesthetic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. k.grupp@uke.de. ^[3]

关键词 Immunohistochemistry Large cell lung carcinoma Lung adenocarcinoma Non-small-cell lung carcinoma RBM3 Squamous cell lung carcinoma